Catheter Precision, Inc.
VTAK- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716621
No open-market purchases or sales by Catheter Precision, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $57.2K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Catheter Precision, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −9 vs. Q3 2022
- Shares held
- 79.8K
- −2.38M (−96.8%) vs. Q3 2022
- Total value
- $469.9K
- +$177.7K (+60.8%) vs. Q3 2022
- New holders
- 6
- 1 more added
- Sold out
- 15
- 5 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTAK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $57.2K |
| Q1 2026 | 12 | $102.9K |
| Q4 2025 | 9 | $125.2K |
| Q3 2025 | 3 | $58 |
| Q2 2025 | 12 | $120.2K |
| Q1 2025 | 10 | $202.3K |
| Q4 2024 | 8 | $216.7K |
| Q3 2024 | 11 | $62.8K |
| Q2 2024 | 14 | $414.5K |
| Q1 2024 | 13 | $389.4K |
| Q4 2023 | 13 | $176.5K |
| Q3 2023 | 14 | $240.8K |
| Q2 2023 | 14 | $382.8K |
| Q1 2023 | 11 | $904.4K |
| Q4 2022 | 12 | $469.9K |
| Q3 2022 | 21 | $292.2K |
| Q2 2022 | 23 | $256.5K |
| Q1 2022 | 26 | $420.0K |
| Q4 2021 | 23 | $1.04M |
| Q3 2021 | 19 | $1.50M |
| Q2 2021 | 15 | $1.95M |
| Q1 2021 | 20 | $3.84M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Catheter Precision, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 18,437 | $108.6K | 0.00% | +18,437 | New |
| Citadel Advisors LLC | 17,094 | $100.7K | 0.00% | +17,094 | New |
| Goldman Sachs Group Inc | 15,479 | $91.2K | 0.00% | +15,479 | New |
| Geode Capital Management, LLC | 13,473 | $79.0K | 0.00% | −65,445−82.9% | Reduced |
| Morgan Stanley | 8,057 | $47.5K | 0.00% | +7,973+9,491.7% | Added |
| UBS Group AG | 5,170 | $30.5K | 0.00% | +5,170 | New |
| Tower Research Capital LLC (TRC) | 1,783 | $10.0K | 0.00% | +1,783 | New |
| Federation des caisses Desjardins du Quebec | 200 | $1.18K | 0.00% | −9,800−98.0% | Reduced |
| Advisor Group Holdings, Inc. | 100 | $1.00K | 0.00% | −5,076−98.1% | Reduced |
| Harbour Investments, Inc. | 20 | $118 | 0.00% | −980−98.0% | Reduced |
| Aspire Private Capital, LLC | 20 | $118 | 0.00% | +20 | New |
| Wells Fargo & Company | 15 | $88 | 0.00% | −350−95.9% | Reduced |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,038,267−100.0% | Sold out |
| WealthTrust Axiom LLC | 0 | $0 | 0.00% | −330,000−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −222,035−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −139,888−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −118,076−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −86,079−100.0% | Sold out |
| Avantax Planning Partners, Inc. | 0 | $0 | 0.00% | −78,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −63,414−100.0% | Sold out |
| Bourne Lent Asset Management Inc | 0 | $0 | 0.00% | −36,848−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −19,394−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −12,310−100.0% | Sold out |
| Alethea Capital Management, LLC | 0 | $0 | 0.00% | −12,320−100.0% | Sold out |
| Guardian Financial Partners, LLC | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Key Financial Inc | 0 | $0 | 0.00% | −110−100.0% | Sold out |